iSpecimen (ISPC) Income from Non-Controlling Interests (2022 - 2026)
iSpecimen (ISPC) posted quarterly Income from Non-Controlling Interests of $1253.0 for Q1 2026, down 93.24% year-over-year from $18540.0 in Q1 2025, and up 12.08% quarter-over-quarter from $1118.0 in Q4 2025.
iSpecimen (ISPC) Income from Non-Controlling Interests (2022 - 2026) Analysis & Trends
iSpecimen's Income from Non-Controlling Interests history runs 5 years deep, the most recent figure standing at $1253.0 for Q1 2026.
- In Q1 2026, Income from Non-Controlling Interests fell 93.24% year-over-year to $1253.0; the TTM figure through Mar 2026 stood at -$9318.0 (down 103.42% YoY), while the FY2025 annual figure was $7969.0, down 82.79% from the prior year.
- Income from Non-Controlling Interests for Q1 2026 stood at $1253.0, up from $1118.0 in the prior quarter.
- The five-year high for Income from Non-Controlling Interests was $3.5 million in Q2 2023, with the low at -$7.8 million in Q4 2023.
- The 5-year median for Income from Non-Controlling Interests is $64000.0 (2024), against an average of $557117.7.
- The sharpest annual moves came in 2024 and 2025: Income from Non-Controlling Interests slumped 108.62% in 2024, then jumped 108.91% in 2025.
- iSpecimen's Income from Non-Controlling Interests stood at $3.1 million in 2022, then tumbled by 352.31% to -$7.8 million in 2023, then surged by 102.44% to $190303.0 in 2024, then plunged by 99.41% to $1118.0 in 2025, then grew by 12.08% to $1253.0 in 2026.
- Business Quant data shows ISPC's Income from Non-Controlling Interests at $1253.0 in Q1 2026, $1118.0 in Q4 2025, and -$2069.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 5.00 Mn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | - |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | - |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | - |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 2.00 Mn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | - |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | - |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | - |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 400,000.00 |
| 10 | iSpecimen | 2.25 Mn | -2.16 Mn | 68,650.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,253.00 |
| Dec 31, 2025 | 1,118.00 |
| Sep 30, 2025 | -2,069.00 |
| Jun 30, 2025 | -9,620.00 |
| Mar 31, 2025 | 18,540.00 |
| Dec 31, 2024 | 190,303.00 |
| Sep 30, 2024 | 64,000.00 |
| Mar 31, 2024 | -208,000.00 |
| Dec 31, 2023 | -7.81 Mn |
| Sep 30, 2023 | 2.11 Mn |
| Jun 30, 2023 | 3.50 Mn |
| Mar 31, 2023 | 2.41 Mn |
| Sep 30, 2022 | 3.10 Mn |
| Jun 30, 2022 | 2.61 Mn |
| Mar 31, 2022 | 2.38 Mn |